85 phenotypes from 11 alleles in 16 genetic backgrounds

Allelic Composition Genetic Background	Annotated Term	Reference
Egln1Gt(RRG405)Byg/Egln1Gt(RRG405)Byg involves: 129P2/OlaHsd	abnormal heart morphology	J:162597
	abnormal response of heart to induced stress	J:162597
	normal cardiovascular system phenotype	J:162597
	decreased body weight	J:162597
	normal hematopoietic system phenotype	J:162597
Egln1tm1.1Brei/Egln1tm1.1Brei Myl2tm1(cre)Krc/Myl2+ B6.Cg-Myl2tm1(cre)Krc Egln1tm1.1Brei	abnormal coronary vessel morphology	J:170943
	abnormal response to cardiac infarction	J:170943
	normal cardiovascular system phenotype	J:170943
	decreased cardiomyocyte apoptosis	J:170943
	decreased myocardial infarct size	J:170943
Egln1tm1.1Brei/Egln1tm1.1Brei Tg(CD68-icre)1Bwlx/0 involves: C57BL/6	abnormal blood viscosity	J:194598
	abnormal lymphocyte cell number	J:194598
	abnormal megakaryocyte progenitor cell morphology	J:194598
	abnormal nucleated erythrocyte cell number	J:194598
	abnormal spleen morphology	J:194598
	enlarged spleen	J:194598
	normal hematopoietic system phenotype	J:194598
	hypervolemia	J:194598
	increased erythroblast number	J:194598
	increased hematocrit	J:194598
	increased spleen weight	J:194598
	normal mortality/aging	J:194598
	polycythemia	J:194598
	postnatal growth retardation	J:194598
	reddish skin	J:194598
	thrombocytopenia	J:194598
Egln1tm1.1Fsl/Egln1+ C57BL/6-Egln1tm1.1Fsl	increased hematocrit	J:202737
	increased hemoglobin content	J:202737
	increased pulmonary ventilation	J:202737
	increased spleen weight	J:202737
	increased tidal volume	J:202737
	polycythemia	J:202737
Egln1tm1.1Fsl/Egln1tm1.1Fsl C57BL/6-Egln1tm1.1Fsl	prenatal lethality, complete penetrance	J:202737
Egln1tm1.1Kael/Egln1tm1.1Kael involves: 129S6/SvEvTac * C57BL/6 * FVB/N	lethality during fetal growth through weaning, complete penetrance	J:132718
Egln1tm1.2Brei/Egln1tm1.2Brei B6.Cg-Egln1tm1.2Brei	preweaning lethality, complete penetrance	J:170943
Egln1tm1Fong/Egln1+ involves: 129S6/SvEvTac * C57BL/6 * FVB/N	normal muscle phenotype	J:132630
Egln1tm1Fong/Egln1tm1Fong involves: 129S6/SvEvTac * C57BL/6 * CD-1 * FVB/N * SJL	abnormal heart morphology	J:114669
	abnormal heart ventricle morphology	J:114669
	abnormal interventricular septum morphology	J:114669
	abnormal lymph organ development	J:114669
	abnormal placenta labyrinth morphology	J:114669
	abnormal placenta morphology	J:114669
	abnormal spongiotrophoblast layer morphology	J:114669
	abnormal trabecula carnea morphology	J:114669
	abnormal trophoblast giant cell morphology	J:114669
	congestive heart failure	J:114669
	decreased trophoblast giant cell number	J:114669
	delayed heart development	J:114669
	embryonic lethality during organogenesis, complete penetrance	J:114669
	increased heart atrium size	J:114669
	pale yolk sac	J:114669
	thin ventricle myocardium compact layer	J:114669
Egln1tm1Kael/Egln1tm1Kael Tg(CAG-cre/Esr1*)5Amc/0 involves: 129S6/SvEvTac * C57BL/6 * CBA	abnormal myocardium layer morphology	J:132718
	blood vessel congestion	J:132718
	cardiac ischemia	J:132718
	decreased body size	J:132718
	dilated cardiomyopathy	J:132718
	hemorrhage	J:132718
	increased circulating erythropoietin level	J:132718
	increased myocardial fiber size	J:132718
	polycythemia	J:132718
	premature death	J:132718
	reddish skin	J:132718
Egln1tm1Kael/Egln1tm1Kael Tg(Myh6-cre)2182Mds/0 involves: 129S6/SvEvTac * FVB/N	abnormal heart left ventricle morphology	J:179490
	cardiac interstitial fibrosis	J:179490
	decreased mitochondrial number	J:179490
	decreased ventricle muscle contractility	J:179490
	enlarged heart	J:179490
	increased angiogenesis	J:179490
	increased heart weight	J:179490
	increased myocardial fiber size	J:179490
	increased response of heart to induced stress	J:179490
	liver vascular congestion	J:179490
	myocardial fiber degeneration	J:179490
	pulmonary vascular congestion	J:179490
Egln1tm1Pec/Egln1tm1Pec Not Specified	prenatal lethality, complete penetrance	J:148719
Egln1tm2.1Fsl/Egln1+ Pax3tm1(cre)Joe/Pax3+ involves: 129 * C57BL/6	increased hematocrit	J:202737
	polycythemia	J:202737
Egln1tm2.1Fsl/Egln1tm2.1Fsl Commd10Tg(Vav1-icre)A2Kio/Commd10+ B6.Cg-Egln1tm2.1Fsl Commd10Tg(Vav1-icre)A2Kio	increased erythroid progenitor cell number	J:202737
	increased hematocrit	J:202737
	increased hemoglobin content	J:202737
	polycythemia	J:202737
Egln1tm2.1Fsl/Egln1tm2.1Fsl Gt(ROSA)26Sortm9(cre/ESR1)Arte/Gt(ROSA)26Sor+ B6.Cg-Gt(ROSA)26Sortm9(cre/ESR1)Arte Egln1tm2.1Fsl	extramedullary hematopoiesis	J:202737
	increased erythropoietin level	J:202737
	increased hematocrit	J:202737
	increased spleen weight	J:202737
	polycythemia	J:202737
	premature death	J:202737
Egln1tm2.1Fsl/Egln1tm2.1Fsl Pax3tm1(cre)Joe/Pax3+ involves: 129 * C57BL/6	abnormal liver vasculature morphology	J:202737
	increased heart weight	J:202737
	increased hematocrit	J:202737
	increased liver weight	J:202737
	increased spleen weight	J:202737
	polycythemia	J:202737
Egln1tm2.1Fsl/Egln1tm2.1Fsl Tg(Cdh5-cre)7Mlia/0 B6.Cg-Egln1tm2.1Fsl Tg(Cdh5-cre)7Mlia	increased heart weight	J:202737
	premature death	J:202737
Egln1tm2.2Fsl/Egln1+ B6.Cg-Egln1tm2.2Fsl	increased hematocrit	J:202737
	increased hemoglobin content	J:202737
	increased pulmonary ventilation	J:202737
	increased spleen weight	J:202737
	polycythemia	J:202737
Egln1tm2.2Fsl/Egln1tm2.2Fsl B6.Cg-Egln1tm2.2Fsl	prenatal lethality, complete penetrance	J:202737
Egln1tm2Fong/Egln1tm2Fong Gt(ROSA)26Sortm1(cre/ERT2)Alj/Gt(ROSA)26Sor+ involves: 129S6/SvEvTac * C57BL/6	abnormal blood vessel morphology	J:133568
	abnormal capillary branching pattern	J:133568
	abnormal capillary morphology	J:133568
	abnormal definitive hematopoiesis	J:132720
	abnormal kidney vasculature morphology	J:133568
	abnormal liver morphology	J:132720
	abnormal lung vasculature morphology	J:133568
	abnormal renal glomerulus morphology	J:133568
	abnormal splenic cell ratio	J:132720
	decreased survivor rate	J:132720
	dilated liver sinusoidal space	J:133568
	dilated vasculature	J:133568
	enlarged liver	J:132720
	enlarged spleen	J:132720
	extramedullary hematopoiesis	J:132720
	increased angiogenesis	J:133568
	increased circulating erythropoietin level	J:132720
	increased hematocrit	J:132720
	increased hemoglobin content	J:132720
	increased leukocyte cell number	J:132720
	polycythemia	J:132720
	premature death	J:132720
	reddish skin	J:132720